Cargando…

Conversion Surgery for Advanced Pancreatic Cancer

While primarily unresectable locally advanced pancreatic cancer (LAPC) used to be an indication for palliative therapy, a strategy of neoadjuvant therapy (NAT) and conversion surgery is being increasingly used after more effective chemotherapy regimens have become available for pancreatic ductal ade...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hank, Thomas, Strobel, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912686/ https://www.ncbi.nlm.nih.gov/pubmed/31718103 http://dx.doi.org/10.3390/jcm8111945

Ejemplares similares

Local radicality and survival outcome of pancreatic cancer surgery
por: Niesen, Willem, et al.
Publicado: (2019)

Oncological Outcome of Conversion Surgery After Preoperative Chemotherapy for Metastatic Pancreatic Cancer
por: Hank, Thomas, et al.
Publicado: (2023)

Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis
por: Leonhardt, Carl Stephan, et al.
Publicado: (2022)

Conversion therapy, palliative chemotherapy and surgery, which of these is the best treatment for locally advanced and advanced pancreatic cancer?
por: Wang, Mingxing, et al.
Publicado: (2021)

Conversion Surgery for Pancreatic Cancer—The Impact of Neoadjuvant Treatment
por: Klaiber, Ulla, et al.
Publicado: (2020)

ASO Author Reflections: Outcomes Support Aggressive Surgery for Early-Onset Pancreatic Cancer
por: Leonhardt, Carl-Stephan, et al.
Publicado: (2022)

Conversion surgery with gemcitabine plus nab-paclitaxel for locally advanced unresectable pancreatic cancer: A case report
por: Okura, Ryosuke, et al.
Publicado: (2018)

Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review
por: Wang, Mingxing, et al.
Publicado: (2020)

Conversion Surgery for Patients with Advanced Gastric Cancer with Peritoneal Carcinomatosis
por: Lee, Ting-Ying, et al.
Publicado: (2021)

A case of successful conversion surgery for locally advanced pancreatic cancer with synchronous triple cancer of the lung and esophagus: a case report
por: Mita, Junya, et al.
Publicado: (2022)

Oligometastatic Pancreatic Cancer to the Liver in the Era of Neoadjuvant Chemotherapy: Which Role for Conversion Surgery? A Systematic Review and Meta-Analysis
por: De Simoni, Ottavia, et al.
Publicado: (2020)

Resected Early-Onset Pancreatic Cancer: Practices and Outcomes in an International Dual-Center Study
por: Leonhardt, Carl-Stephan, et al.
Publicado: (2022)

Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma
por: Satoi, Sohei, et al.
Publicado: (2019)

Cavernous transformation of the portal vein in pancreatic cancer surgery—venous bypass graft first
por: Schmidt, Thomas, et al.
Publicado: (2020)

Conversion surgery for an initially unresectable, locally advanced pancreatic cancer after induction chemotherapy and carbon-ion radiotherapy: a case report
por: Fujishiro, Takeshi, et al.
Publicado: (2018)

A case of successful conversion surgery for gastric cancer with direct invasion to pancreatic head
por: Sato, Manabu, et al.
Publicado: (2021)

Chirurgie periampullärer Pankreaskarzinome
por: Hank, Thomas, et al.
Publicado: (2021)

Nanomaterials for Advanced Photocatalytic Plastic Conversion
por: Kim, Jae Young, et al.
Publicado: (2023)

Advances in pancreatic cancer biomarkers
por: Hasan, Syed, et al.
Publicado: (2019)

Risk-stratification model to select conversion surgery for advanced gastric cancer patients
por: Nie, Runcong, et al.
Publicado: (2019)

The clinical effect of conversion surgery for advanced gastric cancer patients with peritoneal metastasis
por: Shinkai, Masayuki, et al.
Publicado: (2022)

Complete response of locally advanced left-sided pancreatic cancer after modified FOLFIRINOX chemotherapy followed by conversion surgery: A case report
por: Kim, Sun Jung, et al.
Publicado: (2021)

Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Center
por: Mita, Naoki, et al.
Publicado: (2021)

ADVANCES IN LAPAROSCOPIC PANCREATIC SURGERY
por: Martel, Gareth, et al.
Publicado: (2019)

Advances in Early Detection of Pancreatic Cancer
por: Kanno, Atsushi, et al.
Publicado: (2019)

Erlotinib in the treatment of advanced pancreatic cancer
por: Kelley, Robin K, et al.
Publicado: (2008)

Familial pancreatic cancer: genetic advances
por: Rustgi, Anil K.
Publicado: (2014)

Systemic Chemotherapy in Advanced Pancreatic Cancer
por: Lee, Hee Seung, et al.
Publicado: (2016)

Novel agents for advanced pancreatic cancer
por: Akinleye, Akintunde, et al.
Publicado: (2015)

Recent advances in the treatment of pancreatic cancer
por: Roth, Marc T, et al.
Publicado: (2020)

Advances and Prospects in the Treatment of Pancreatic Cancer
por: Duan, Huaiyu, et al.
Publicado: (2023)

Systemic treatment for advanced pancreatic cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

The Role of Circular RNAs in Pancreatic Ductal Adenocarcinoma and Biliary-Tract Cancers
por: Limb, Christopher, et al.
Publicado: (2020)

Conversion pancreaticoduodenectomy with dual arterial reconstructions for locally advanced pancreatic cancer: Case report and literature review
por: Kimura, Yasutoshi, et al.
Publicado: (2021)

Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma
por: Yanagimoto, Hiroaki, et al.
Publicado: (2020)

Surgery for Recurrent Pancreatic Cancer: Is It Effective?
por: Moletta, Lucia, et al.
Publicado: (2019)

Conversion Surgery in Gastric Cancer Carcinomatosis
por: Morgagni, Paolo, et al.
Publicado: (2022)

Carbon-based electrocatalysts for advanced energy conversion and storage
por: Zhang, Jintao, et al.
Publicado: (2015)

Recent Advances in the Reverse Water–Gas Conversion Reaction
por: Zhou, Changjian, et al.
Publicado: (2023)

Clinical Outcomes of Conversion Surgery after Neoadjuvant Chemotherapy in Patients with Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer: A Single-Center, Retrospective Analysis
por: Yoo, Changhoon, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aoj66tj1ad0fmgtu9vef6lpdv3